Quanterix

Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts. 

Application note: A Simoa™ Bridging Assay for Anti Drug Antibody Detection

Application note: A Simoa ^™ Pharmacokinetic Bridging Assay

Application note: Cell Lysate Sample Handling with Simoa Bead-Based Assays

Application note: Analysis of Inflammatory Plasma Biomarkers in Cancer Patient Samples

Application note: Ultra-sensitive Homebrew Assay